Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The annual BIO International conference is large. Very ...

MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and ...

Kelowna, British Columbia – June 5, 2025 –TheNewswire -Lexaria Bioscience Corp. (LEXX) (Nasdaq: LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that ...

Bio-Path Holdings will host a conference call on May 29, 2025, to discuss its business overview and pipeline developments. Bio-Path Holdings, Inc., a biotechnology company focused on developing cancer ...

The two-day event brought together a mix of researchers, startup founders and industry professionals in the Maryland life sciences community. Conference panelists. Today, the Maryland Tech Council ...

The company’s reliance on future clinical trial results introduces significant uncertainty regarding the potential success of its drug candidates, highlighting risks that may deter investors. The ...

THRiVE is Virginia Bio’s largest statewide event. It is a conference that brings together the leading researchers from biomedical research universities and health systems, entrepreneurs, startups and ...

MINNEAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m.